Singapore (SG)

Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's Letter to the Editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469–82. (2023) Rubin MA, Amin MB, Compérat E, Gill A, Hartmann A, Menon S, Raspollini M, et al. Journal article Intelligent Surfaces Empowered 6G Wireless Network (2023) Wu Q, Duong TQ, Ng DWK, Schober R, Rui Z Authored book Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis. (2023) Grams ME, Coresh J, Matsushita K, Ballew SH, Sang Y, Surapaneni A, Alencar De Pinho N, et al. Journal article Transparent reporting of research-related greenhouse gas emissions through the scientific CO2nduct initiative (2022) Sweke R, Boes P, Ng N, Sparaciari C, Eisert J, Goihl M Journal article The deep space quantum link: prospective fundamental physics experiments using long-baseline quantum optics (2022) Mohageg M, Mazzarella L, Anastopoulos C, Gallicchio J, Hu BL, Jennewein T, Johnson S, et al. Journal article, Review article A tribute to Prof. Ondrej Hes, MD, PhD (1968-2022) (2022) Alaghehbandan R, Agaimy A, Ali L, Alvarado-Cabrero I, Amin MB, Boudova L, Calio A, et al. Journal article International comparisons of laboratory values from the 4CE collaborative to predict COVID-19 mortality (2022) Weber GM, Hong C, Xia Z, Palmer NP, Avillach P, L'Yi S, Keller MS, et al. Journal article WHO 2022 classification of penile and scrotal cancers: updates and evolution (2022) Menon S, Moch H, Berney DM, Cree IA, Srigley JR, Tsuzuki T, Comperat E, et al. Journal article Global Matrix 4.0 Physical Activity Report Card Grades for Children and Adolescents: Results and Analyses From 57 Countries (2022) Aubert S, Barnes JD, Demchenko I, Hawthorne M, Abdeta C, Nader PA, Sala JCA, et al. Journal article Neoadjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy, followed by adjuvant pembrolizumab versus placebo for early-stage TNBC: Event-free survival sensitivity and subgroup analyses from KEYNOTE-522 (2022) Schmid P, Cortes J, Dent R, Pusztai L, Mcarthur H, Kuemmel S, Bergh J, et al. Conference contribution